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investigated mushroom species in various cultures as food 
or alternative medicines, their Li-biofortified forms could 
potentially find social acceptance. The concentrations of Li 
accumulated in fruiting bodies were not high enough for 
application in psychiatric treatments but could potentially 
support the daily intake of Li for behavior modification or 
health beneficiary purposes. Further studies are necessary 
to fully investigate the safety implications of Li-enriched 
mushrooms for humans.
Keywords Lithium · Biofortification · Ganoderma 
lucidum · Pleurotus eryngii · Pleurotus ostreatus
Introduction
Mood disorders, including bipolar disorder, represent an 
important category of mental illnesses, whose prevalence 
is generally increasing in developed countries. Over the 
years, a number of psychopharmacological agents have 
been introduced, with lithium (Li) cation being one of the 
most promising and effective, primarily in the recovery of 
bipolar affective disorder [1]. However, its potential thera-
peutic application spectra are much wider with evidence 
supporting its use in the treatment of unipolar depression 
[2], acute mania and its prophylactic [3, 4], or reduction in 
suicidal and aggressiveness rates in affective disorders [5, 
6] and conduct disorder [7]. It is also speculated whether 
Li could be used in treating neurodegenerative disorders 
including Alzheimer’s disease and, importantly, its preven-
tion [8]. Apart from a purely applied medical use, some 
authors have suggested that nutritional intake of Li could 
be potentially beneficial for mood stabilization and may 
lead to a decrease in aggressive behavior in the general 
population [9–11].
Abstract It has recently been suggested that food fortifica-
tion with Li is worth serious consideration as a strategy to 
support psychiatric treatment and decrease violent behav-
iors in the general population. Therefore, the present study 
developed the cultivation of three commercially important 
mushroom species, Ganoderma lucidum, Pleurotus eryn-
gii and Pleurotus ostreatus, on substrates enriched with 
Li (0.25–1.0 mM) in the form of acetate or carbonate. The 
growth of the mycelium colony, production of fruiting bod-
ies and accumulation of Li were evaluated. Analysis of Li 
was performed using an optical emission spectrometry with 
excitation by inductively coupled plasma using an Agi-
lent 5100 ICP-OES spectrometer. As found, Li2CO3 was 
a more bioavailable form although it had a greater adverse 
effect on mushroom growth. Substrate supplementation 
with CH3COOLi resulted in lower or no growth retarda-
tion but decreased uptake of Li. The most promising results 
were obtained for G. lucidum, which accumulated up to 
73.58 ± 10.87 (Li2CO3) and 25.59 ± 9.98 (CH3COOLi) 
mg Li kg−1 dry mass. Given the popularity of the 
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Unlike many traditional psychopharmacological com-
pounds, Li does not bind to a cellular receptor but modifies 
the intracellular second messenger system. Its main postu-
lated mechanisms of action are based on effects excreted on 
inositol monophosphatase (IMPase) within the phosphati-
dylinositol (PI) signaling pathway and the protein kinase 
glycogen synthase kinase 3β (GSK-3β) [12]. Calcium car-
bonate taken orally as pills is the most often applied form 
[13]. However, Li may also be supplied in relatively low 
doses with diet, particularly through consumption of grains 
and vegetables, and also in some areas with drinking water 
[14]. Interestingly, decreased levels of dietary intake of Li 
have been potentially linked to the prevalence of manic-
depressive psychosis [15] and rates of suicides, homicides, 
or even the arrest rates for drug use and other crimes [16]. 
Altogether, this supports the hypothesis that Li consump-
tion with food may have prophylactic value in the primary 
prevention of mood disorder [17]. However, most food 
products are poor in Li [14], while the use of Li-containing 
pharmaceuticals is likely to be socially linked with serious 
mental illness [10].
Information on natural Li content in mushrooms is 
scarce. Its mean concentration reported for wild-growing 
mushrooms collected from different locations in Hungary 
and Italy amounted only to 0.19 and 0.25 mg kg−1 dry 
weight, respectively [18, 19], while in cultivated Pleuro-
tus mushrooms, Li content was found to be below detec-
tion limit [20]. Recently, however, the concept of mush-
rooms enriched in various elements such as selenium, zinc 
or copper for use as functional foods has been developed 
[21–23]. Mushrooms are a potentially rich target of such a 
biofortification strategy owing to their ability to accumu-
late various elements present in the overgrown substrates 
[24]. They also represent traditional natural products used 
widely in various cuisines [25], and some species are well 
recognized for their potential medicinal use [26]. Moreo-
ver, commercial cultivation of mushrooms can be made 
cost- and time-effective [27]. And Li fortification of food 
has recently been highlighted as worth serious considera-
tion [9]. Li-enriched mushrooms may represent an inter-
esting and more socially acceptable alternative in dietary 
supplementation of this element for various health benefi-
ciary purposes. Nevertheless, to date the bioenrichment of 
mushrooms with Li has largely been ignored—only one 
study assessed the ability of P. ostreatus to accumulate Li 
added to the cultivation substrate in the form of LiCl [28]. 
As reported, the supplementation significantly increased Li 
concentrations in fruiting bodies (reaching maximally over 
150 mg kg−1) and did not alter crude protein content.
The aim of the present study was to evaluate the feasi-
bility of mushroom species: G. lucidum (known as “Chi-
nese Lingzhi”), P. eryngii and P. ostreatus (known as 
“king oyster” and “oyster” mushroom, respectively) for 
bioenrichment with Li in the form of carbonate and acetate. 
All three mushrooms are commercially important species, 
valued for their nutritional properties, with various medici-
nal uses reported in in vitro and in vivo studies [29, 30]. 
Our study highlights that they may additionally represent 
promising carriers of dietary Li.
Materials and methods
Experimental design
The substrate for P. ostreatus was prepared from a mixture 
of beech and alder sawdust (1:1 vol.), additionally supple-
mented with wheat bran in the amount of 20%, wheat straw 
chaw 10%, corn flour 5%, soybean meal 3%, chalk 1% and 
gypsum 1% in relation to the substrate weight. For P. eryn-
gii and G. lucidum, a mixture of beech and alder sawdust 
was also used, but the following supplements were added: 
wheat bran 20%, corn flour 5%, soybean meal 3%, sucrose 
1% and gypsum 1%. The mixtures were moistened to 45% 
of water content using distilled water, placed in polypropyl-
ene bags and sterilized at 121 °C for 1 h. Li was added to 
the substrate in the form of solutions prepared from Li2CO3 
or CH3COOLi (Sigma-Aldrich) in concentrations of 0.25, 
0.5, 0.75 and 1.0 mM. The moisture of the substrates after 
Li addition was 60%. The substrates were mixed with 
grain spawn of tested mushroom species (5% of substrate 
weight) and placed in 17 × 25 cm polypropylene foil bags 
with a filter (P. ostreatus and G. lucidum) or in 1-L poly-
propylene bottles with a cellulose filter type 338 (Munktell, 
Bärenstein, Germany) with a basic weight of 84 g/m2 and 
typical retention of 12–15 μm (P. eryngii).
Sterile Petri dishes for mycelium growth testing were 
used. The dishes were filled with the examined substrates 
after which three grains of mushroom spawn were placed 
in their central part. Incubation was conducted at 25 °C for 
9 days. After that time, the diameter of the mycelium col-
ony was noted.
The incubation in bags and bottles was conducted at 
25 °C and 80–85% relative humidity until the substrate 
became completely covered with mycelium. Next, the 
bottles with removed covers and bags with the top part of 
the foil cut off were placed in a cultivation chamber. For 
fructification, humidity was maintained at 85–90% and 
temperature at 16 ± 1 °C for P. ostreatus and P. eryngii 
and at 25 ± 1 °C for G. lucidum. The cultivation cham-
ber was illuminated with fluorescent light of 500 lx inten-
sity for 12 h a day and aerated to maintain CO2 concen-
tration below 1000 ppm. Fruiting bodies of P. eryngii and 
P. ostreatus were harvested successively as they matured. 
Yield included fruiting bodies with stipes from one flush 
of yielding for P. eryngii and two flushes for P. ostreatus. 
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Fruiting bodies of G. lucidum were harvested at once 
45 days after inoculation.
Mushroom fruiting bodies were dried in an electric 
drier SLW 53 STD (Pol-Eko, Wodzisław S´la˛ski, Poland) 
at 50 °C for 48 h, weighted and ground for 0.5 min in a 
Cutting Boll Mill 200 (Retsch GmbH, Haan, Germany). 
The powdered samples were treated in the extraction. The 
method described above was similar to that presented in the 
author’s previous studies [21].
Instrument
An optical emission spectrometer with excitation by 
inductively coupled plasma Agilent 5100 ICP-OES (Agi-
lent, USA) was used in radial plasma observation mode 
(wavelength 670.783 nm, radio frequency (RF) power 
1.2 kW, nebulizer gas flow 0.7 L min−1, auxiliary gas flow 
1.0 L min−1, plasma gas flow 12.0 L min−1, viewing height 
8 mm, signal accusation time 5 s for three replicates). The 
commercial analytical standard (Romil, England) was used 
for analysis. The detection limits were determined on the 
level of 0.01 mg kg−1 dry weight (DW as three-sigma crite-
ria). The uncertainty for total analytical procedure (includ-
ing sample preparation) was at the level of 20%. Results 
recovery of standard addition (used due to a lack of certi-
fied standard materials for phosphoric acid extraction) was 
80–120%.
Procedure
Mushrooms were dried at 50 ± 2 °C for 24 h and at 
80 ± 2 °C for 8 h in an electric oven (SLW 53 STD, 
Pol-Eko, Wodzisław S´la˛ski, Poland) to dry matter and 
then ground in a laboratory Cutting Boll Mill PM 200 
(Retsch GmbH, Haan, Germany). Accurately weighed 
0.300 ± 0.001 g of a dry sample of mushroom was ultra-
sonically extracted by phosphoric acid 1 mol L−1 solution 
(Honeywell, USA). After extraction, samples were filtered 
and diluted with water to a final volume of 15.0 mL. Each 
of the samples was analyzed in triplicate using the whole 
sample preparation procedure.
Statistical analysis
The results were analyzed using STATISTICA 12.0 soft-
ware (StatSoft, USA). One-way analysis of variance 
(ANOVA) followed by the post hoc Tukey’s HSD test was 
applied to investigate the differences in Li accumulation 
and mushroom growth between the studied species. Cor-
relations between Li content in fruiting bodies and their 
biomass were assessed with the Pearson correlation coef-
ficient. P < 0.05 was considered as statistically significant.
Results
The effect of Li on the mycelium colony
The addition of Li2CO3 and CH3COOLi resulted in a dis-
tinctively different response of mycelium growth (Fig. 1). 
Higher levels of Li2CO3 (0.75 and 1.0 mM for P. eryngii 
and G. lucidum, and ≥0.5 mM for P. ostreatus) signifi-
cantly altered the mycelium colony growth (Fig. 1). In the 
presence of all concentrations of CH3COOLi, mycelium of 
all three species developed intensively.
The effect of Li on fruiting body morphology 
and biomass
The characteristics of fruiting bodies obtained from Li-
enriched cultivation are collectively presented in Fig. 2. 
Most cultivation models did not induce any visible macro-
scopic alterations. P. eryngii did not grow on substrates sup-
plemented initially with 0.75 and 1 mM of Li2CO3, whereas 
fruiting bodies of G. lucidum were clearly deformed and 
lower in the presence of 1 mM of Li2CO3 (Fig. 2).
The biomass of the collected fruit bodies depended 
more on mushroom species than on the form of Li used 
for supplementation (Fig. 3). Generally, the greatest bio-
mass was produced by P. eryngii grown with Li2CO3 and 
CH3COOLi (mean for all concentrations was 96.0 ± 1.2 
and 93.7 ± 5.0 g, respectively), while the lowest biomass 
was observed for P. ostreatus collected from the second 
flush of yielding (37.6 ± 7.6 and 41.5 ± 7.3 g, respec-
tively). Biomass of G. lucidum fruiting bodies, in turn, was 
generally comparable over different CH3COOLi concen-
trations and significantly affected by the highest level of 
Li2CO3 employed in this study. Similarly, CH3COOLi did 
not induce significant changes in the biomass of P. ostrea-
tus from the first flush of yielding, contrary to Li2CO3 
which decreased mushroom biomass at the greatest sub-
strate concentrations (0.75 and 1 mM).
Efficiency of lithium accumulation in mushroom species
The form of Li used in the experiment was crucial in its 
uptake and accumulation in mushroom fruiting bodies 
(Fig. 4). Generally, the accumulated content increased 
over the initial Li concentration. In most cases, a greater 
mean content of Li was noted when substrates were supple-
mented with Li2CO3 than CH3COOLi. It should, however, 
be noted that P. eryngii did not grow at higher Li2CO3 con-
centrations. The greatest mean content of Li was found for 
G. lucidum, exceeding 70 mg kg−1 dm after the substrate 
was enriched with 1 mM of Li as Li2CO3 and 25 mg kg
−1 
dm following the substrate supplementation with 1 mM of 
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Li in the form of CH3COOLi. The maximum accumulation 
for P. ostreatus first flush was 12.0 mg kg−1 (Li2CO3) and 
8.3 mg kg−1 (CH3COOLi) and P. ostreatus second flush 
16.5 mg kg−1 (Li2CO3) and 5.3 mg kg
−1 (CH3COOLi), and 
for P. eryngii, it amounted to 10.9 mg kg−1 (Li2CO3) and 
15.1 mg kg−1 (CH3COOLi).
There was a significant negative correlation between 
Li concentrations in fruiting bodies of G. lucidum, P. 
Fig. 1  Characteristics of 
mycelium colony of the studied 
mushroom species
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eryngii and P. ostreatus first flush of yielding in the pres-
ence of Li2CO3, and the biomass of their fruiting bod-
ies (r = −0.98, r = −0.76 and r = −0.93, respectively; 
p < 0.05). No statistically significant correlations were 
found between these two parameters when mushrooms 
were grown in the presence of CH3COOLi and when 
P. ostreatus second flush of yielding was cultivated with 
substrates supplemented with Li2CO3 (p > 0.05 in all cases).
Fig. 2  Morphology of mushroom species growing on substrate enriched with lithium carbonate and lithium acetate
Fig. 3  Biomass (g) of mush-
room species
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Discussion and conclusions
The bioenrichment of mushrooms during their cultivation 
process is becoming increasingly studied as a promising 
strategy to produce functional foods [22, 23, 31]. It has 
been suggested that nutritional intake of Li may be benefi-
cial for health, particularly in the prevention or ameliora-
tion of neurological and psychiatric alteration [32, 33]. The 
present study demonstrates that in fact, some mushrooms 
species may easily uptake Li from the overgrown substrate 
and efficiently accumulate it in their fruiting bodies without 
a significant alteration of their growth and morphology.
Potential commercial application of Li-enriched mush-
rooms as a nutraceutical would require their cultivation 
to be cost-effective and efficient as regards produced bio-
mass. An artificially increased content of various elements 
in cultivation substrate may largely affect the growth and 
appearance of mushrooms and result in increased cultiva-
tion expenses as well as a decrease in the attractiveness 
of the final product for potential consumers and a lower 
market value [22, 34]. As demonstrated, the cultivated 
species were generally more resistant to Li in the form of 
acetate and developed a greater mycelium colony and sub-
sequently larger biomass of fruiting bodies. This is in line 
with results obtained by Nunes et al. [35] who compared 
the growth of various white-rot fungi on potato dextrose 
agar supplemented with different forms of Li: acetate, 
chloride, hydroxide, sulfate and carbonate. The latter was 
found to be the most toxic; in its presence, no mycelium 
growth was observed for most of the investigated species 
(including P. eryngii). It should be highlighted that all Li 
compounds employed by Nunes et al. [35] decreased mush-
room growth several-fold (except for P. djamor) compared 
to the control. This largely discourages the employment 
of non-composted substrates in enrichment of mushrooms 
with Li as the bioavailability of this element may be too 
high and lead to toxic effects. Previous investigations by de 
Assunção et al. [28] indicated that P. ostreatus may be suc-
cessfully cultivated on coffee husk substrate supplemented 
with Li chloride. Our study adds further evidence that solid 
substrates with CH3COOLi and Li2CO3 can also be used in 
bioenrichment of fruiting bodies.
Particularly promising results of the present study 
were obtained for G. lucidum. This species grew well 
on substrates supplemented with every concentration of 
CH3COOLi, and in this case, maximal accumulation in 
fruiting bodies exceeded 25 mg kg−1 dry matter (DM). 
Although higher concentrations of Li2CO3, 0.75 and 
1.0 mM, significantly decreased the biomass, the Li accu-
mulation exceeded 40 and 60 mg kg−1 dry matter, respec-
tively. The commercial application of Li-enriched G. 
lucidum may be additionally supported for the medicinal 
properties of this species, which have long been acknowl-
edged [29, 36–38]. Considering that the market for G. luci-
dum is already worth over 2.5 billion US dollars [39], the 
commercial introduction of its Li-enriched form should not 
be troublesome. The safety of such a product should be first 
evaluated, preferably using both in vitro and in vivo mod-
els; its target group of potential consumers should be then 
clearly defined, presumably on the bases of randomized tri-
als conducted on various populations.
The use of Li in the treatment of psychiatric disorders 
requires relatively high daily doses taken orally. These 
may even rise to as much as 600–1200 mg of Li2CO3 taken 
daily in divided doses, which equates to 113–226 mg of 
elemental Li [40]. Our study demonstrated that a single 
consumption of a meal containing 100 g of dried G. luci-
dum, P. ostreatus first flush, P. ostreatus second flush and 
Fig. 4  Content of Li 
(mg kg−1 dry matter) in fruit 
bodies of mushroom species
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P. eryngii would constitute 7.4, 1.2, 1.6 and 1.9 mg of Li 
intake if substrates were fortified with 1 mM of Li2CO3 (or 
0.5 mM in case of P. eryngii). To compare, consumption 
of the same amount of mushrooms grown on substrates 
supplemented with 1 mM of CH3COOLi would equal a 
Li intake of 2.6 mg (G. lucidum), 0.8 mg (P. ostreatus first 
flush), 0.5 mg (P. ostreatus second flush) and 1.5 mg (P. 
eryngii). These calculations, however, do not include the 
partial loss, which may occur during mushroom process-
ing, e.g., washing or cooking [25, 41]. Moreover, they do 
not consider the absorption kinetics in the gastrointestinal 
tract, although in vitro bioavailability of Li from mush-
rooms was reported to be very high, far surpassing that 
of the pharmaceutical drug containing Li2CO3 [28]. Alto-
gether, it is more likely that Li-enriched mushrooms such 
as G. lucidum, P. ostreatus and P. eryngii may find a practi-
cal application in prophylactics of mood alterations rather 
than in psychiatric treatment. Importantly, moderately 
increased Li consumption may also be beneficial in stabi-
lizing the mood of former alcoholics and drug users [32, 
42]. Such food products could ensure an adequate dietary 
intake of Li for the purpose of decreasing the frequency 
of aggression and violence, as supported by observations 
that suicides, anxiety and homicides may be linked to low 
serum Li levels [43–45]. To maintain its physiological lev-
els, the provisional recommended dietary allowance for Li 
in adults has been proposed at the level of 1 mg for a 70-kg 
adult, although tenfold higher doses were not reported to 
induce any adverse health effects [14]. To meet the nutri-
tional demand for Li, some authors have recently suggested 
that cereal grain products be fortified with Li, or Li be 
added to dietary supplements [9]. Mushrooms may be an 
interesting or even superior option in this regard if one con-
siders their popularity in different cuisines, their traditional 
use in various cultures for the maintenance of health and 
disease prevention and their social acceptance as foodstuffs 
[26]. All three species investigated in our study could serve 
as a source of moderately increased dietary Li at doses far 
below those reported to be toxic for humans [14]. On the 
other hand, the present study demonstrated relatively high 
variations of Li content in mushroom fruiting bodies as 
presented by SD values for each Li concentration, which 
may be a challenge in standardizing the Li levels in final 
food products obtained from such mushrooms. Further 
biomedical investigations, including experimental in vitro 
and in vivo models, are necessary to evaluate the medical 
potential of Li-enriched mushrooms.
In summary, the present study evaluated whether three 
commercially important mushroom species may be used 
in Li biofortification in order to produce Li-enriched 
fruiting bodies. Apart from investigating the Li accumu-
lation, its effect on the mycelium colony and the biomass 
of fruiting bodies was also assessed. The most promising 
effects were obtained for G. lucidum, both in terms of 
growth and in terms of Li accumulation. The adoption of 
this species may be particularly interesting in increasing 
the dietary intakes of Li for mood modulation purposes, 
given its already established medicinal status. Mush-
rooms biofortified with Li may find their use in decreas-
ing rates of aggressive behaviors—a hypothesis yet to 
be tested in randomized control trials preceded by safety 
evaluations.
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